Harmony Market Capitalization from 2010 to 2024
| HRMY Stock | USD 33.23 0.44 1.34% |
Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 28.4 M, Depreciation And Amortization of 14.7 M or Interest Expense of 17.9 M, as well as many indicators such as Price To Sales Ratio of 3.14, Dividend Yield of 0.0 or PTB Ratio of 4.32. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.
Harmony | Market Capitalization |
Latest Harmony Biosciences' Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Harmony Biosciences Holdings over the last few years. It is Harmony Biosciences' Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harmony Biosciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 1.9 B | 10 Years Trend |
|
Market Cap |
| Timeline |
Harmony Market Capitalization Regression Statistics
| Arithmetic Mean | 2,019,881,103 | |
| Geometric Mean | 1,990,565,238 | |
| Coefficient Of Variation | 19.77 | |
| Mean Deviation | 272,984,559 | |
| Median | 1,822,343,199 | |
| Standard Deviation | 399,248,589 | |
| Sample Variance | 159399.4T | |
| Range | 1.4B | |
| R-Value | 0.49 | |
| Mean Square Error | 130331.1T | |
| R-Squared | 0.24 | |
| Significance | 0.06 | |
| Slope | 43,805,057 | |
| Total Sum of Squares | 2231592.1T |
Harmony Market Capitalization History
About Harmony Biosciences Financial Statements
Harmony Biosciences investors use historical fundamental indicators, such as Harmony Biosciences' Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania. Harmony Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 180 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Harmony Stock Analysis
When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.